Beagles are the most commonly used dogs in pharmaceutical safety testing, with welfare needs that are frequently inadequately met in standard laboratory housing conditions.
Beagles in pharmaceutical research experience welfare deficits rooted in housing that does not accommodate their social and activity needs during studies that may last a year or more. The docility that makes them useful research subjects also makes them vulnerable — they tolerate poor conditions without the aggressive responses that might signal welfare problems more visibly. Enrichment through human socialisation, play, social housing and voluntary training for procedure cooperation represents achievable refinement. Re-homing post-study beagles extends welfare consideration beyond the research period. Supporting organisations that facilitate laboratory dog re-homing and companies that commit to it is a direct and practical welfare contribution.